IL6 and Alzheimer disease: This type of nanoparticles inhibited the accumulation of Aβ, reactive oxygen species (ROS), tumor necrosis factor-alpha (TNF-α), and Interleukin 6 (IL-6) and raised the concentrations of superoxide dismutase (SOD) and synapse levels in the brains of AD mice [32].